54th European Pancreatic Club Meeting

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of MedExpert and LLC STARFISH-KF certified for CME credit. MedExpert is accredited by the ACCME to provide continuing medical education for physicians.

MedExpert designates this activity for a maximum of 23 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Pre-Congress European Pancreatic Club EPC-2022 Course

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of MedExpert and LLC STARFISH-KF certified for CME credit. MedExpert is accredited by the ACCME to provide continuing medical education for physicians.

MedExpert designates this activity for a maximum of 7 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Program

pdf

Last update 21 June 2022

Central European Summer Time (CEST)

Lecture
Break
Poster discussion session
Workshop
Closing
Assembly
Sponsor Symposium
State-of-art-lecture
Pre-Congress course

Wednesday June 22

Hall 1

09:00 - 10:00
Nutrition and quality of life in pancreatic cancer patients
(Workshop proposed by PCE)
09:00 - 09:05
Opening
Maria Luisa Pagano
09:05 - 09:10
Welcome message
Alfredo Carrato
09:10 - 09:20
Cancer nutrition guidelines with a specific focus on pancreatic cancer
Rocco Barazzoni
09:20 - 09:30
Nutrition in Surgical patients with pancreatic cancer
Sorin T. Barbu
09:30 - 09:35
Q&A
09:35 - 09:45
Plenary discussion with guiding questions to exchange experiences and best practices
09:45 - 09:55
Update on PCE Nutrition project
Marien Castillo Sanchez
09:55 - 10:00
Conclusions and closing of the event
Sorin T. Barbu
10:00 - 10:10
Break
10:10 - 10:50
Proteases, lipases and pancreatitis
Julia Mayerle - Anders Molven
10:10 - 10:30
The regulation of the immune response determines the course of pancreatitis
Matthias Sendler
10:30 - 10:50
Protease storm in hereditary pancreatitis
Andrea Geisz
10:50 - 11:00
Break
11:00 - 15:00
Basic science - free papers
Jozsef Maleth - Alexei Tepikin
11:00 - 11:20
Identification of molecular heterogeneity in pancreatic ductal adenocarcinoma by multivariate profiling of unfolded protein response - PCE-DS1211
Dana Sochorova
11:20 - 11:40
Dysregulation of the RNA surveillance machinery in pancreatic cancer: Searching for novel sources of biomarkers and therapeutic targets - PCE-RB939
Ricardo Blazquez-Encinas
11:40 - 12:00
A lysosomal lipid switch sensitizes to nutrient deprivation and mTOR targeting in pancreatic cancer - PCE-MD2001
Maria Chiara De Santis
12:00 - 12:20
Applying an automated image-based algorithm to measuring cancer spheroid viability in a high throughput setting - PCE-BG307
Beate Gündel
12:20 - 12:40
Unravelling the impact of exosomes in pancreatic cancer metastasis through a new organotypic-liver slide culture system - PCE-AC1017
Annalisa Comandatore
12:40 - 13:20
Break
13:20 - 13:40
COA4 Impairs Cell Migration in Pancreatic Ductal Adenocarcinoma via its downstream mediator PLAU - CMB-YY908
Malte Buchholz
13:40 - 14:00
The pancreatic proteases as new analgesic targets in acute and chronic pancreatitis - ACPE-OS513
Okan Safak
14:00 - 14:20
The tissue remodeling of chronic pancreatitis is driven by a local type 2 immune response - ACPE-JG206
Juliane Glaubitz
14:20 - 14:40
CFTR activity is determined store-independently by SPCA2/STIM1/ORAI1 complex in secretory epithelial cells - CMB-AV1310
Arpad Varga
14:40 - 15:00
Polymorphisms in Transcription Factor Binding Sites and Enhancers as Pancreatic Ductal Adenocarcinoma Risk Factors - G-PU6205
Pelin Unal
15:00 - 15:10
Break
15:10 - 17:40
YOUPPIE Section EPC 2022 Kyiv
15:10 - 15:15
Introduction, YOUPPIE Today
Andrii Khomiak - Giovanni Marchegiani - Hanna Sternby
15:15 - 15:30
The Waterfall trial
Enrique De Madaria
15:30 - 15:45
The PORSCH trial
Jasmijn Smiths
15:45 - 16:00
Consensus definition of microlithiasis and sludge as cause of biliary pancreatitis
Simon Sirtl
16:00 - 16:15
Definition and grading of post pancreatectomy acute pancreatitis (PPAP)
Elisa Bannone
16:15 - 17:00
Three young scientists from Ukraine: being a pancreatologist in Ukraine and being a Ukrainian pancreatologist abroad in 2022
Andrii Khomiak - Oleksandra Lanhazo - Liudmyla Pererva
17:00 - 17:10
YOUPPIE award session with introduction and talks from the two awardees
17:10 - 17:25
Addressing a key challenge of pancreatic cancer: early detection
Acedo Pilar
17:25 - 17:40
Targeting mutant KRAS - renaissance of concept, opportunities and challenges for pancreatic cancer
Dietrich Ruess
17:40 - 17:45
End of the congress day

Wednesday June 22

(Pre-Congress Course) Hall 2

09:00 - 09:05
Welcome speech
Andriy Dorofeyev
09:05 - 11:05
Potential pathogenic links of gut microbiome and pancreatic pathology
Andriy Dorofeyev - Cindy Neuzillet
09:05 - 09:35
Gut microflora in pancreatic diseases: possible pathogenic mechanisms and risks
Albrecht Neesse
09:35 - 10:05
Alpha-1 antitrypsin deficiency: pancreatic-pulmonary – gut axes
Joanna Chorostowska
10:05 - 10:35
The microbiota and immune system crosstalk in pancreatic diseases
Gulustan Babayev
10:35 - 11:05
Syndrome of increased epithelial permeability in pancreatic pathology
Marco Romano - Kateryna Priadko
11:05 - 11:15
Break
11:15 - 13:15
Gut microbiome changes in pancreatic diseases
Albrecht Neesse - Sergyi Tkach
11:15 - 11:45
Role of gut microbiota on intestinal barrier function in acute pancreatitis
Igor Khomiak - Olexander Rotar - Sorin T. Barbu
11:45 - 12:15
The gut microbiome in patients with chronic pancreatitis
Markus Lerch
12:15 - 12:45
Exocrine pancreatic insufficiency association with changes in intestinal microbiota composition
Dan Dumitrascu
12:45 - 13:15
Gut microbiota: its potential roles in pancreatic cancer
Cindy Neuzillet
13:15 - 13:55
Break
13:55 - 15:55
Microbiome and liver diseases
Andriy Dorofeyev - Tarkan Karakan
13:55 - 14:25
Morphological association of liver pathology with changes in the intestinal microbiome
Olena Dyadyk
14:25 - 14:55
The role of diet in gut microbiome modulation in non-alcoholic fatty liver disease
Oleg Shvets
14:55 - 15:25
Microbiome and autoimmune liver diseases
Sevda Agayeva
15:25 - 15:55
Gut microbiota in liver cirrhosis and its complications
Alexander Nersesov - Jamilya Kaibullayeva
15:55 - 16:05
Break
16:05 - 18:05
Bowel diseases in pancreatic pathology and therapeutic potential of microbial modulation in pancreatic diseases
Dan Dumitrascu - Marco Romano
16:05 - 16:35
Irritable bowel syndrome and exocrine pancreatic insufficiency
Tarkan Karakan
16:35 - 17:05
IBD and chronic pancreatitis: extraintestinal manifestations or concomitant disease
Andriy Dorofeyev
17:05 - 17:35
Questions about the use of antibiotics in pancreatic disorders
Gulustan Babayeva
17:35 - 18:05
Fecal microbiota transplantation in chronic pancreatitis treatment
Sergyi Tkach
18:05 - 18:15
Conclusions and closing of the pre-course

Thursday June 23

Hall 1

09:00 - 09:15
Opening Ceremony and Introduction
Matthias Löhr - Natalya Gubergrits
09:15 - 09:30
Looking back at the roots
Paul Georg Lankisch
09:30 - 10:50
Membrane channels in physiology and pathophysiology of exocrine pancreas
Fred Gorelick - Ole H. Petersen - Robert Sutton
09:30 - 09:50
The beneficial effect of CFTR restoration in acute pancreatitisis
Viktoria Venglovecz
09:50 - 10:10
The role of different cell types in exocrine pancreas in health and disease
Julia Gerasimenko
10:10 - 10:30
Plasma membrane Ca2+ channels in the physiology and pathology of the pancreas
Jozsef Maleth
10:30 - 10:50
Ion channels and transporters in (pancreatic) cancer pathophysiology
Albrecht Schwab
10:50 - 11:00
Break
11:00 - 12:40
Autoimmune Pancreatitis
Julia Mayerle - Vinciane Rebours
11:00 - 11:20
Why is follow-up of autoimmune pancreatitis important?
Miroslav Vujasinovic
11:20 - 11:40
Autoimmune pancreatitis: where are we now?
Enrique De Madaria
11:40 - 11:55
Autoimmune Pancreatitis in Europe: Clinical Profile and Response to Treatment
Kasper A. Overbeek
11:55 - 12:10
Long-term outcomes from a large cohort of type-1
Marco Lanzilotta
12:10 - 12:25
Autoimmune pancreatitis type 2 and inflammatory bowel disease: bicentric analysis and systematic review of the literature
Sara Nikolic
12:25 - 12:40
Incidence of endocrine and exocrine insufficiency in patients with autoimmune pancreatitis at diagnosis and after treatment
Marco Tacelli
12:40 - 14:10
Improving of quality of life in patients with PEI due to PERT with pancreatin in minimicrospheres
Symposium by ABBOTT
12:40 - 13:02
Secondary PEI
Enrique De Madaria
13:02 - 13:24
Treatment of Primary and Secondary PEI
Miroslav Vujasinovich
13:24 - 13:46
Ladder to Happiness
Natalya Gubergrits
13:46 - 14:10
PEI in patients with functional and inflammatory bowel diseases
Andriy Dorofeyev
14:10 - 14:40
Break
14:40 - 15:00
EPC Lifetime Award Lecture
Non-alcoholic fatty pancreas disease - clinical consequences
Petr Dite - Matthias Löhr
15:00 -15:30
Poster discussion session - SURGERY and ENDOSCOPY
Andrii Klimenko - Roberto Valente
15:03 - 15:06
Video grading of the pancreatic anastomosis during robotic pancreatoduodenectomy to assess learning curve and risk of pancreatic fistula - PS-BV1632
Bram Van den Broek
15:06 - 15:09
Postoperative serum hyperamylasemia (POH) adds value to the Fistula Risk Score (FRS) in predicting pancreatic fistula after pancreatoduodenectomy - PS-EB633
Elisa Bannone
15:09 - 15:12
Prevention of insufficiency of creatojejunoanastomosis during pancreatoduodenal resection using falciform ligament of the liver - PS-NV306
Nikolai Veligotsky
15:12 - 15:15
Intraoperative blood loss estimation in hepato-pancreato-biliary surgery: relevant, not reported, not standardized. Results from a systematic review and a worldwide snapshot survey - PS-GP417
Giampaolo Perri
15:15 - 15:18
Technical tips to optimize the surgical view during robotic-assisted pancreaticoduodenectomy? - PS-YI018
Yosuke Inoue
15:18 - 15:21
Management of clinically-relevant postoperative pancreatic fistula related fluid collections after distal pancreatectomy - PS-GG1021
Giovanni Guarneri
15:21 - 15:24
Outcomes of Combined management Biliary and Gastric Outlet Obstruction (CABRIOLET Study): a multicentre retrospective analysis - PS-GV904
Giuseppe Vanella
15:24 - 15:27
Exploring a Novel Composite Diagnostic Tool Using Non-contrast EUS Enhanced Cyst WallMicrovascular Imaging and Cyst Fluid Analysis to Differentiate Pancreatic Cystic Neoplasms - PS-GK1612
Glenn Koleth
15:27 - 15:30
Clinical relevance of pancreatic fistula in pancreas transplantation: a Comprehensive Complication Index (CCI)-based analysis of postoperative outcomes and predictors of graft survival - PS-CM730
Cristina Martinez Chicote
15:30 - 16:50
Bioenergetics / metabolism / metabolomics of pancreatitis and pancreatic cancer
Federico Canzian - Jozsef Maleth - Alexei Tepikin
15:30 - 15:50
Fuelling calcium pumps in pancreatitis and pancreatic cancer
Jason Bruce
15:50 - 16:10
The cellular stress response as an efficient therapeutic target for PDAC
Juan Iovanna
16:10 - 16:30
Using new-onset diabetes for early detection of pancreatic cancer
Eithne Costello
16:30 - 16:50
Translational research in pancreatitis: from bed to bench to bedside
Peter Hegyi
16:50 - 17:00
Break
17:00 - 17:55
Recent advances in pancreatic endoscopy
Ihor Nastashenko - Petro Ogorodnik
17:00 - 17:20
Endoscopic ultrasound drainage of pancreatic pseudocysts
Ivan Tereshkevych
17:20 - 17:40
Fine needle aspiration (FNA) and fine needle biopsy (FNB) of the pancreas
Lidziya Tarasenka
17:40 - 17:55
Endoscopic Papillectomy compared to Surgery for Non-Invasive Ampullary Lesions and early Ampullary Cancers - a Pancreas2000 /European Pancreatic Club - Study
Marcus Hollenbach
17:55 - 18:35
Recent advances in pancreatic surgery and radiotherapy
Marco Del Chiaro - Oleksandr Usenko
17:55 - 18:15
Radiotherapy in combined treatment of pancreatic cancer
Sergey Zemskov
18:15 - 18:35
Recent advances in pancreatic surgery
Helmut Friess
18:35 - 18:40
End of the congress day

Friday June 24

Hall 1

07:30 - 09:00
Council Meeting
09:00 - 10:00
Pancreatic tumors
Helmut Friess - Igor Khomiak - Giovanni Marchegiani
09:00 - 09:15
Gut microbiota and pancreatic cancer: any connection?
Margaret Sällberg-Chen
09:15 - 09:30
Neuroendocrine tumors of the pancreas sporadic or MEN1 - which difference
Sebastian Gaujoux
09:30 - 09:45
Surgical treatment of malignant periampullary tumors
Oleksandr Usenko
09:45 - 10:00
Surgical treatment of metastatic pancreatic cancer
Sohei Satoi
10:00 - 10:10
Break
10:10 - 11:30
Pancreatic tumors (continuation)
Djuna Cahen - Roberto Valente
10:10 - 10:25
Surgical treatment of locally advanced pancreatic cancer. Vascular resectionsand reconstructions
Marco Del Chiaro
10:25 - 10:40
Familial pancreatic cancer
Kyoichi Takaori
10:40 - 10:50
Usefulness of endoscopic ultrasound (EUS)-guided elastography for the diagnosis of malignancy of solid pancreatic tumors. Analysis of a large prospective registry from a referal center
Julio Iglesias-Garcia
10:50 - 11:00
Surgical indication and outcomes of conversion surgery for initially unresectable locally advanced pancreatic cancer
Yuta Yoshida
11:00 - 11:10
Strategy of neoadjuvant therapy for resectable/borderline resectable pancreatic ductal adenocarcinoma
Daisuke Hashimoto
11:10 - 11:20
Enucleation of pancreatic insulinomas: early- and long-term results of open surgery in 43 years experience in a single center
Anna Caterina Milanetto
11:20 - 11:30
Extended pancreatectomy in treatment of patients with pancreatic cancer (our experience)
Volodymyr Kopchak
11:30 - 12:00
Round table discussion - poster discussion session - PANCREATIC TUMORS
Ryan Baron - Konstantin Kopchak
11:30 - 11:33
The diagnostic and prognostic value of apelin (APLN) and serum amyloid A3 (SAA3) adipocytokine measurement in patients with pancreatic ductal adenocarcinoma (PDAC) compared to chronic pancreatitis (CP) and healthy subjects
Michal Jacub Stasiak
11:33 - 11:36
Bile volatile organic compounds in diagnostics of pancreatic cancer and biliary obstruction: a prospective proof-of-concept study
Ville Teränen
11:36 - 11:39
Survival Outcomes of Pancreatic Tumors in Pediatric Population: Analysis of NCDB and SEER Databases
Andrii Khomiak
11:39 - 11:42
It is not necessary to resect all Mucinous Cystic Neoplasms of the Pancreas: Current guidelines do not reflect the actual risk of malignancy A Systematic review and Meta-Analysis
Tommaso Pollini
11:42 - 11:45
Very early recurrence after R0\\R1 resection for pancreatic ductal adenocarcinoma: proof of concept for a “BIOLOGICAL R2” definition
Giulio Belfiori
11:45 - 11:48
Heat shock protein 90: target structure in acute pancreatitis and pancreatic ductal adenocarcinoma
Aistė Kielaitė-Gulla
11:48 - 11:51
The immune microenvironment in pancreatic ductal adenocarcinoma: a potential preoperative marker of lymphnodal involvement
Ottavia De Simoni
11:51 - 11:54
Integration of serum, stool, and urine metabolomic profiles for pancreatic cancer risk prediction
Francisco Jurado
11:54 - 11:57
Dynamics and costs of patients with appropriate, “too early” and “too late” surgery in low-risk Intraductal Papillary Mucinous Neoplasms
Domenico Tamburrino
12:00 - 13:30
Hot Topics in Pancreatic Exocrine Insufficiency - A round table debate about diagnosis and treatment of PEI in clinical practice
J. Enrique Dominguez-Muñoz
Panelists: Marco Bruno - Matthias Löhr - Vinciane Rebours
13:30 - 13:40
Break
13:40 - 15:25
Chronic pancreatitis
J. Enrique Domínguez Muñoz - Galina D. Fadeenko - Matthias Löhr - Igor Skrypnyk
13:40 - 13:55
Understanding pancreatic fibrogenesis: implications for disease progression and treatment
Apte Minoti
13:55 - 14:10
Pancreatic pain: treatment options
Asbjørn Mohr Drewes
14:10 - 14:40
Surgery is always superior to endoscopy in chronic pancreatitis?
Güralp O. Ceyhan - László Czakó
14:40 - 14:55
Staging of chronic pancreatitis - are we any closer?
Georg Beyer
14:55 - 15:05
Post-pancreatitis diabetes mellitus – a high-volume tertiary center experience
Ana Dugic
15:05 - 15:15
Pancreatic exocrine insufficiency, diabetes mellitus and malnutrition in chronic pancreatitis: data from the basquenavarrese registry of chronic pancreatitis (pan-eus).
Clara Urteaga Casares
15:15 - 15:25
Genetic factors behind the recurrence of pediatric pancreatitis - results from the APPLE-R (Analysis of Pediatric Pancreatitis) prospective, multicentre, observational clinical study
Andrea Párniczky
15:25 -15:55
Poster discussion session
Oleg Shvets - Heiko Witt
15:25 - 15:28
The effect of alpha-lipoic acid on adipocytokine level in patients with type 2 diabetes mellitus and chronic pancreatitis
Larysa Zhuravlyova
15:28 - 15:31
Quality of life of patients with chronic pancreatitis who need surgical treatment
Mariana Fedorkiv
15:31 - 15:34
Prevalence and factors associated with sarcopenia in a cohort of patients with chronic pancreatitis
Mikel Ganuza
15:34 - 15:37
Quality of life and stress assessment in patients with acute and chronic pancreatitis: preliminary results of the Goulash-Plus clinical trial
Veronika Lillik
15:37 - 15:40
The incidence of recurrent acute pancreatitis and chronic pancreatitis after acute pancreatitis. A systematic review and meta-analysis.
Endre-Botond Gagyi
15:40 - 15:43
Genetic and Idiopathic chronic pancreatitis display distinct clinical features at diagnosis
Chiara Deli
15:43 - 15:46
Endoscopic procedures and quality of life in chronic pancreatitis patients
Mikael Parhiala
15:46 - 15:49
Correction of pathogenetic effects of liver disease on the course of chronic pancreatitis with diabetes mellitus
Liliya Babinets
15:49 - 15:52
Anatomical and physiological orientation is the fundamental principle of surgical treatment of patients with chronic pancreatitis with ductal hypertension
Volodimyr Klymenko
15:52 - 16:05
Break
16:05 - 17:20
Acute pancreatitis
Gabriele Capurso - Johanna Laukkarinen
16:05 - 16:20
SARS-CoV-2 infection and acute pancreatitis. Evidence for support!
Sanjay Pandanaboyana
16:20 - 16:35
Hypertriglyceridemia-induced acute pancreatitis
Vinciane Rebours
16:35 - 16:50
Modern treatment strategies of acute pancreatitis
Davor Stimac
16:50 - 17:00
Thoracic epidural analgesia as an effective analgesic technique and potential disease-modifying therapy for acute pancreatitis: Results from a systematic review
Rex Wan-Hin Hui
17:00 - 17:10
Anticoagulants decrease mortality and major complication rates in moderately severe and severe acute pancreatitis – a systematic review and meta-analysis
Cristina Patoni
17:10 - 17:20
The predictive scores for acute pancreatitis severity have limited clinical usefulness: a systematic review and meta-analysis with pre and post test probability assessment
Gabriele Capurso
17:20 - 17:45
Poster discussion session
Stefan Krstevsky - Olexander Rotar
17:20 - 17:23
SARS-CoV-2 infection is associated with an increased risk of idiopathic acute pancreatitis but not pancreatic exocrine insufficiency or diabetes: long-term results of the COVIDPAN study - ACPC-CV311
Chris Varghese
17:23 - 17:26
Results of treatment fluid collections in acute pancreatitis using minimally invasive procedures - ACPC-IK220"
Igor Kryvoruchko
17:26 - 17:29
Strategy of Surgical Interventions in Patients with Complicated Acute Necrotizing Pancreatitis - ACPC-IK524
Igor Khomiak
17:29 - 17:32
Comparison of presepsin and procalcitonin for prognosis of infectious complication of acute necrotizing pancreatitis - ACPC-OH525
Oleksandr Hrama
17:32 - 17:35
Post-discharge mortality is an overlooked outcome measure in acute pancreatitis. A prospective international cohort analysis of 3237 patients - ACPC-DC755
Dóra Czapári
17:35 - 17:38
Correlation between abdominal perfusion pressure and timing ofinfection of pancreatic necrosis in patients with acute severe pancreatitis - ACPC-OD546
Ivanna Shchyhel
17:38 - 17:41
Polymorphisms of the tumour necrosis factor alpha (TNF-α) gene and the severity of acute pancreatitis: a systematic review and meta-analysis - ACPC-WC217
Wing Kiu Chou
17:41 - 17:43
Endocrine and exocrine insufficiency after a 2-year follow-up of acute pancreatitis: preliminary results of the GOULASH-PLUS study - ACPC-AM1247
Vera Lillik
18:30 - 19:45
General assembly
19:45 - 19:50
End of the congress day

Saturday June 25

Hall 1

09:00 - 10:00
Signalling mechanisms in pancreatitis and pancreatic cancer
Maria del Pilar Acedo Nuñez - Juan Iovanna - Francisco X. Real - Aldo Scarpa
09:00 - 09:20
Proinflammatory signaling pathways in the transition phase of pancreatitis and pancreatic cancer
Hana Algül
09:20 - 09:40
Towards the identification of cancer-associated fibroblast signaling underlying pancreatic cancer aggressiveness
Corinne Bousquet
09:40 - 10:00
Complex lipids in pancreatic cancer – a neglected field
Julia Mayerle
10:00 - 10:55
Poster discussion session
Aldo Scarpa - Sergyi Tkach
10:00 - 10:05
Characterization of adhesion and migratory abilities of epithelial and mesenchymal pancreatic cancer cell populations with different cancer stem cell properties - PCE-UY319
Umut-Ulas Yesilyurt
10:05 - 10:10
Impact of cancer stem cell markers Nestin and Sox2 on cell migration of epithelial and mesenchymal pancreatic cancer cells - PCE-AM428
Amelie Modi
10:10 - 10:15
Impact of targeted SHP2-inhibition +/- MAPK-Inhibition on metabolic rewiring in pancreatic cancer - PCE-PH318
Philipp Hafner
10:15 - 10:20
The effect of bile on pancreatic cancer, the importance of mucins - PCE-EG908
Eleonóra Gál
10:20 - 10:25
Neuronal glutamate promotes pancreatic cancer cell migration through neuro-cancer synapses that fuel the GRIN2D-EZH2-E2F1-RB pathway - PCE-LR342
Ren Lei
10:25 - 10:30
Organization of pancreatic acinar cells is regulated by stellate cells in a three-dimensional co-culture model - CMB-MB202
Merja Bläuer
10:30 - 10:35
POLr3K Regulates Pancreatic Ductal Adenocarcinoma Cell Growth via miR-30d-5p - CMB-YY907
Malte Buchholz
10:35 - 10:40
The inhibition of the mitochondrial Na+/Ca2+ exchanger prevents acinar cell damage in acute pancreatitis in mice - ACPE-NC611
Noémi Csákány-Papp
10:40 - 10:45
Effect of recombinant human thrombomodulin on rat experimental sever acute pancreatitis - ACPE-MM1108
Masataka Matsumoto
10:45 - 10:50
The role of TRPV6 variants in the Hungarian chronic pancreatitis population - G-ZP813
Zsofia Gabriella Pesei
10:50 - 10:55
Investigation of the endocrine phenotype in the MODY8 mouse - DEEI-JA901
Jahedul Alam
10:55 - 11:30
Break
11:30 - 13:10
Clinical and translational pancreatology: what's new?
Thomas Gress - Natalia V. Kharchenko - Patrick Michl
11:30 - 11:50
Enzyme preparations of non-animal origin. Pro and Con
Jonas Rosendahl
11:50 - 12:10
Pediatric aspects of pancreatic pathology
Heiko Witt
12:10 - 12:30
Laboratory diagnostics of pancreatic diseases and functional tests: “the king is dead” or “long live the king!”
J. Enrique Domínguez Muñoz
12:30 - 12:50
Latest evidence-based research in pancreatology: whats new?
David Whitcomb
12:50 - 13:10
Endoscopic ultrasound (EUS) and the pancreas
Julio Iglesias-Garcia
13:10 - 13:25
EPC, the past, present and future
Matthias Löhr
13:25 - 13:40
Closing the meeting
Matthias Löhr - Natalya Gubergrits
13:40 - 13:55
Welcome to Munich 2023
Heiko Witt
13:55 - 14:00
End of the congress day